Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

Novo Seeds

Novo A/S is the holding company of the Novo Group, and is wholly owned by the Novo Nordisk Foundation. Novo A/S was established in 1999 to manage the assets of the Foundation and actively make investments on behalf of the Foundation. Novo A/S is not a corporate strategic fund; Novo A/S invests for financial rather than strategic returns. Novo A/S is active in both Europe and North America. The Novo A/S venture investments are managed by a team of four Partners in Copenhagen, one in London and three in San Francisco. With an evergreen structure, Novo A/S annually invests approximately EUR 200 million through Novo Ventures, Novo Seeds, and Novo Growth Equity. In total Novo A/S has more than EUR 15 billion under management, which includes significant shareholdings in the independently operating and publicly listed companies Novo Nordisk A/S and Novozymes A/S. *


Period Start 2011-05-03 existent
  Group Novo Group (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Christgau, Stephan (Eir Ventures 202007– before Novo Seeds + Osteologix)
  Person 2 Grotkjær, Thomas (Novo Group 201809 Principal at Novo Seeds)
Region Region Hellerup
  Country Denmark
  Street 19 Tuborg Havnevej
c/o Novo A/S
  City 2900 Hellerup
  Tel +45-3527-6500
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Delenex Therapeutics AG. (5/3/11). "Press Release: Delenex Extends Its A Round to CHF 30.2 Million. Thomas Dyrberg from Novo A/S Joins the Board of Directors". Schlieren.
Record changed: 2020-12-16


Picture [iito] Plain Stupid Simple 650x80px

More documents for Novo Group (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

» top